Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Chany, P. Duc-Goiran, B. Robert-Galliot, T. Chudzio, P. Lebon (1982)STUDY OF HUMAN AMNIOTIC INTERFERON
S. Cheeseman, R. Rubin, J. Stewart, N. Tolkoff-Rubin, A. Cosimi, K. Cantell, J. Gilbert, S. Winkle, J. Herrin, P. Black, P. Russell, M. Hirsch (1979)Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections.
The New England journal of medicine, 300 24
H. Koren, S. Anderson, D. Fischer, C. Copeland, P. Jensen (1981)Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins.
Journal of immunology, 127 5
J. Williams, A. Szentivanyi (1983)Continued studies on the effect of interferon inducers on the hepatic microsomal mixed-function oxidase system of rats and mice.
Journal of interferon research, 3 2
I. Gresser, M. Tovey, C. Maury, I. Chouroulinkov (1975)Lethality of interferon preparations for newborn mice
R. Jahiel, D. Taylor, N. Rainford, S. Hirschberg, R. Kroman (1971)Inducers of interferon inhibit the mitotic response of liver cells to partial hepatectomy.
Proceedings of the National Academy of Sciences of the United States of America, 68 4
Gerald Sonnenfeld, C. Harned, '. Suthep, Thaniyavarn, Thomas Huff, Adrian Mandel, '. DONALDE.NERLAND (1980)Type II interferon induction and passive transfer depress the murine cytochrome P-450 drug metabolism system
Antimicrobial Agents and Chemotherapy, 17
E. Saksela (1980)[Interferon and natural killer cells].
Duodecim; laaketieteellinen aikakauskirja, 96 16
R. Gisler, P. Lindahl, I. Gresser (1974)Effects of interferon on antibody synthesis in vitro.
Journal of immunology, 113 2
P. Morahan, A. Munson, W. Regelson, S. Commerford, L. Hamilton (1972)Antiviral activity and side effects of polyriboinosinic-cytidylic acid complexes as affected by molecular size.
Proceedings of the National Academy of Sciences of the United States of America, 69 4
K. Iwasaki, H. Noguchi (1982)Effect of hepatic microsomal mixed-function oxidase activities in rats pretreated with Nocardia rubra cell wall skeleton.
Research communications in chemical pathology and pharmacology, 37 2
D. Ikić, Z. Maricić, V. Orešić, B. Rodé, P. Nola, K. Smudj, M. Kneževič, D. Jušić, E. Šooš (1981)APPLICATION OF HUMAN LEUCOCYTE INTERFERON IN PATIENTS WITH URINARY BLADDER PAPILLOMATOSIS, BREAST CANCER, AND MELANOMA
The Lancet, 317
R. Smalley (1986)Interferon in the treatment of cancer.
The Medical clinics of North America, Suppl
Ralph Freedman, Gutterman Ju, Wharton Jt, Rutledge Fn (1983)Leukocyte interferon (IFN alpha) in patients with epithelial ovarian carcinoma.
Journal of biological response modifiers, 2 2
S. Pestka, S. Baron (1981)Definition and classification of the interferons.
Methods in enzymology, 78 Pt A
H. Smedley, M. Katrak, K. Sikora, T. Wheeler (1983)Neurological effects of recombinant human interferon.
British Medical Journal (Clinical research ed.), 286
J. Zarling, J. Sosman, L. Eskra, E. Borden, J. Horoszewicz, W. Carter (1978)Enhancement of T cell cytotoxic responses by purified human fibroblast interferon.
Journal of immunology, 121 5
P. Lebon, S. Girard, F. Thépôt, C. Chany (1982)The presence of alpha-interferon in human amniotic fluid.
The Journal of general virology, 59 Pt 2
T. Matsuno, N. Shirasawa, S. Kohno (1976)Interferon suppresses glutamine synthetase induction in chick embryonic neural retina.
Biochemical and biophysical research communications, 70 1
P. Nair, M. Tong, R. Kempf, R. Co, Shou‐dong Lee, Cheryl Venturi (1985)Clinical, serologic, and immunologic effects of human leukocyte interferon in HBsAg‐positive primary hepatocellular carcinoma
A. Fowler, C. Reed, D. Giron (1980)Identification of an interferon in murine placentas
H. Cooper, R. Fagnani, J. London, J. Trepel, E. Lester (1982)Effect of interferons on protein synthesis in human lymphocytes: enhanced synthesis of eight specific peptides in T cells and activation-dependent inhibition of overall protein synthesis.
Journal of immunology, 128 2
M. Kawakita, B. Cabrer, H. Taira, M. Rebello, E. Slattery, H. Weideli, P. Lengyel (1978)Purification of interferon from mouse Ehrlich ascites tumor cells.
The Journal of biological chemistry, 253 2
R. Friedman, G. Lee, S. Shifrin, S. Ambesi-Impiombato, D. Epstein, H. Jacobsen, L. Kohn (1982)Interferon interactions with thyroid cells.
Journal of interferon research, 2 3
MD RETSAS, MD PRIESTMAN, F. NEWTON, Frcs WESTBURY (1983)Evaluation of human lymphoblastoid interferon in advanced malignant melanoma
Oldham Rk (1985)Interferon: a model for future biologicals.
Foon Ka, G. Dougher (1984)Increased growth of eyelashes in a patient given leukocyte A interferon.
The New England journal of medicine, 311 19
J. Galabru, N. Robert, C. Buffet‐Janvresse, Y. Rivière, A. Hovanessian (1985)Continuous production of interferon in normal mice: effect of anti-interferon globulin, sex, age, strain and environment on the levels of 2-5A synthetase and p67K kinase.
The Journal of general virology, 66 ( Pt 4)
E. Declercq, Torrence Pf (1981)Structure-activity relationships for interferon induction and inhibition of protein synthesis by polynucleotides.
Texas reports on biology and medicine, 41
I. Gresser, Chantel Maury, M. Tovey, L. Morel‐Maroger, F. Pontillon (1976)Progressive glomerulonephritis in mice treated with interferon preparations at birth
David Farquhar, J. Benvenuto, N. Kuttesch, Ti Loo (1983)Inhibition of hepatic drug metabolism in the rat after Corynebacterium parvum treatment.
Biochemical pharmacology, 32 7
G. Just, C. Simonovitch (1967)A prostaglandin synthesis.
Tetrahedron letters, 22
I. Tamm, L. Pfeffer, E. Wang, F. Landsberger, James Murphy (1981)INHIBITION OF CELL PROLIFERATION AND LOCOMOTION BY INTERFERON: MEMBRANE AND CYTOSKELETAL CHANGES IN TREATED CELLS
D. Weigent, M. Langford, E. Smith, J. Blalock, G. Stanton (1981)Human B lymphocytes produce leukocyte interferon after interaction with foreign cells
Infection and Immunity, 32
H. Kirchner, M. Scott, H. Hirt, K. Munk (1978)Protection of mice against viral infection by Corynebacterium parvum and Bordetella pertussis.
The Journal of general virology, 41 1
Masataka Nakamura, T. Manser, G. Pearson, M. Daley, M. Gefter (1984)Effect of IFN-γ on the immune response in vivo and on gene expression in vitro
J. Berek, N. Hacker, A. Lichtenstein, T. Jung, C. Spina, R. Knox, J. Brady, T. Greene, L. Ettinger, L. Lagasse, E. Bonnem, R. Spiegel, J. Zighelboim (1985)Intraperitoneal Recombinant α-Interferon for “Salvage” Immunotherapy in Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
Cancer Research, 45
R. Derynck, J. Content, E. Declercq, G. Volckaert, J. Tavernier, R. Devos, W. Fiers (1980)Isolation and structure of a human fibroblast interferon gene
J. Horoszewicz, S. Leong, M. Ito, R. Buffett, C. Karakousis, E. Holyoke, L. Job, J. Dölen, W. Carter (1978)Human fibroblast interferon in human neoplasia: clinical and laboratory study.
Cancer treatment reports, 62 11
J. Gutterman, M. Rosenblum, A. Rios, H. Fritsche, J. Quesada (1984)Pharmacokinetic study of partially pure gamma-interferon in cancer patients.
Cancer research, 44 9
H. Schnaper, T. Aune, C. Pierce (1983)Suppressor T cell activation by human leukocyte interferon.
Journal of immunology, 131 5
Kuttikkatt Chandrabose, Pedro Cuatrecasas, Raveendran Pottathil (1981)Changes in fatty acyl chains of phospholipids induced by interferon in mouse sarcoma S-180 cells.
Biochemical and biophysical research communications, 98 3
V. Kushnaryov, H. MacDonald, J. Sedmak, S. Grossberg (1983)Ultrastructural distribution of interferon receptor sites on mouse L fibroblasts grown in suspension: ganglioside blockade of ligand binding
Infection and Immunity, 40
Abernathy Co, Hyman Zimmerman, R. Utili (1980)Effects of endotoxin-tolerance on in vivo drug metabolism in mice.
Research communications in chemical pathology and pharmacology, 29 1
M. Revel (1984)The Interferon System in Man: Nature of the Interferon Molecules and Mode of Action
Borden Ec (1983)Interferons and cancer: how the promise is being kept.
D. Schmucker (1978)Age-related changes in drug disposition.
Pharmacological reviews, 30 4
M. Franklin, B. Finkle (1985)Effect of murine gamma-interferon on the mouse liver and its drug-metabolizing enzymes: comparison with human hybrid alpha-interferon.
Journal of interferon research, 5 2
Kwen-Jen Chang (1984)Opioid peptides have actions on the immune system
Trends in Neurosciences, 7
C. Nathan, H. Murray, Imichael Wlebe, B. Rubin (1983)Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity
The Journal of Experimental Medicine, 158
G. Mannering, K. Renton, R. Azhary, L. Deloria (1980)EFFECTS OF INTERFERON‐INDUCING AGENTS ON HEPATIC CYTOCHROME P‐450 DRUG METABOLIZING SYSTEMS *
Annals of the New York Academy of Sciences, 350
J. Yoon, C. Cha, G. Jordan (1983)The role of interferon in virus-induced diabetes.
The Journal of infectious diseases, 147 1
P. Torrence, E. Clercq (1984)Interferon Induction by Nucleic Acids: Structure-Activity Relationships
T. Merigan, K. Rand, R. Pollard, P. Abdallah, G. Jordan, R. Fried (1978)Human leukocyte interferon for the treatment of herpes zoster in patients with cancer.
The New England journal of medicine, 298 18
J. Maeyer-Guignard, E. Maeyer, M. Tovey, I. Gresser (1980)ELECTROPHORETICALLY PURE MOUSE INTERFERON EXERTS MULTIPLE BIOLOGICAL EFFECTS *
Annals of the New York Academy of Sciences, 350
D. Fischer, M. Golightly, H. Koren (1983)Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.
Journal of immunology, 130 3
Marcus Pi (1983)Interferon induction by viruses: one molecule of dsRNA as the threshold for interferon induction.
A. Field, A. Tytell, G. Lampson, M. Hilleman (1967)Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.
Proceedings of the National Academy of Sciences of the United States of America, 58 3
R. Sundmacher, D. Neumann‐Haefelin, K. Cantell (1982)The Clinical Value of Interferon in Ocular Viral Diseases
J. Jett, A. Mantovani, R. Herberman (1980)Augmentation of human monocyte-mediated cytolysis by interferon.
Cellular immunology, 54 2
D. Barnes, P. Morahan, S. Loveless, A. Munson (1979)The effects of maleic anhydride-divinyl ether (MVE) copolymers on hepatic microsomal mixed-function oxidases and other biologic activities.
The Journal of pharmacology and experimental therapeutics, 208 3
E. Hull, B. Löwenberg, M. Vries, H. Schellekens (1978)Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro.
Cancer research, 38 4
L. Kohn, R. Friedman, J. Holmes, G. Lee (1976)Use of thyrotropin and cholera toxin to probe the mechanism by which interferon initiates its antiviral activity.
Proceedings of the National Academy of Sciences of the United States of America, 73 10
K. Renton, G. Singh, N. Stebbing (1984)Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450.
Biochemical pharmacology, 33 23
K. Apostolov, W. Barker (1984)Cyclic effects of interferon and its antagonist on the saturation of 18-carbon fatty acids
Annales De L'institut Pasteur. Virologie, 135
V. Bocci (1981)PRODUCTION AND ROLE OF INTERFERON IN PHYSIOLOGICAL CONDITIONS
Biological Reviews, 56
C. Rochette-Egly, M. Tovey (1982)Interferon enhances guanylate cyclase activity in human lymphoma cells.
Biochemical and biophysical research communications, 107 1
T. Sreevalsan, E. Rozengurt, And TAYLOR-PAPADIMITRIOU, J. Burchell, Imperial Cancer, PO Fund, Boz No, 123, Lincolns Inn, London Fie, Wcza (1980)Differential effect of interferon on DNA synthesis, 2‐deoxyglucose uptake and ornithine decarboxylase activity in 3T3 cells stimulated by polypeptide growth factors and tumor promotors
Journal of Cellular Physiology, 104
S. Sherwin, K. Foon, P. Abrams, M. Heyman, J. Ochs, T. Watson, A. Maluish, R. Oldham (1984)A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer.
Journal of biological response modifiers, 3 6
I. Gresser (1983)The Antitumor Effects of Interferon in Mice
J. Quesada, D. Swanson, A. Trindade, J. Gutterman (1983)Renal cell carcinoma: antitumor effects of leukocyte interferon.
Cancer research, 43 2
A. Arvin, David Martin, E. Gard, T. Merigan, S. Feldman, J. Kushner (1982)ALPHA-INTERFERON IN SIMIAN AND HUMAN VARICELLA
R. Luftig, J. Conscience, A. Skoultchi, P. McMillan, M. Revel, F. Ruddle (1977)Effect of interferon on dimethyl sulfoxide-stimulated Friend erythroleukemic cells: ultrastructural and biochemical study
Journal of Virology, 23
K. Renton (1983)CHAPTER 11 – Relationships between the Enzymes of Detoxication and Host Defense Mechanisms
P. Chandra, M. Woltersdorf (1976)Tilorone hydrochloride--a specific probe for A-T regions of duplex deoxyribonucleic acid.
Biochemical pharmacology, 25 8
Patriarca Pa, Kendal Ap, Stricof Rl, Weber Ja, Meissner Mk, B. Dateno (1983)Influenza vaccination and warfarin or theophylline toxicity in nursing-home residents.
The New England journal of medicine, 308 26
H. Miörner, L. Landström, E. Larner, I. Larsson, E. Lundgren, O. Strannegard (1978)Regulation of mitogen-induced lymphocyte DNA synthesis by human interferon of different origins.
Cellular immunology, 35 1
D. Tyrrell (1976)Interferon and its clinical potential
K. Foon, S. Sherwin, P. Abrams, D. Longo, M. Fer, H. Stevenson, J. Ochs, G. Bottino, C. Schoenberger, J. Zeffren (1984)Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon.
The New England journal of medicine, 311 18
B. Lebleu, J. Content (1982)Mechanisms of interferon action: biochemical and genetic approaches.
T. Sharpe, P. Birch, D. Planterose (1971)Resistance to virus infection during the hyporeactive state of interferon induction.
The Journal of general virology, 12 3
M. Ja, Baughcum Sd, Levy Hb, Baer Gm (1979)Further studies on rabies postexposure prophylaxis in mice: a comparison of vaccine with interferon and vaccine.
Journal of General Virology, 42
W. Stewart (1979)The Interferon System
E. Chang, F. Jay, R. Friedman (1978)Physical, morphological, and biochemical alterations in the membrane of AKR mouse cells after interferon treatment.
Proceedings of the National Academy of Sciences of the United States of America, 75 4
G. Scullard, R. Pollard, Joseph Smith, S. Sacks, P. Gregory, W. Robinson, T. Merigan (1981)Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
The Journal of infectious diseases, 143 6
J. Gutterman, Seymour Fine, J. Quesada, S. Horning, J. Levine, R. Alexanian, Leon Bernhardt, M. Kramer, Herbert Spiegel, W. Colburn, P. Trown, T. Merigan, Z. Dziewanowski (1982)Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.
Annals of internal medicine, 96 5
Rossi Gb (1985)Interferons and cell differentiation.
E. Knight, B. Korant (1977)A cell surface alteration in mouse L cells induced by interferon.
Biochemical and biophysical research communications, 74 2
T. Taniguchi, N. Mantei, M. Schwarzstein, S. Nagata, M. Muramatsu, C. Weissmann (1980)Human leukocyte and fibroblast interferons are structurally related
G. Scullard, G. Scullard, L. Andres, L. Andres, H. Greenberg, H. Greenberg, Joseph Smith, Joseph Smith, V. Sawhney, V. Sawhney, E. Neal, E. Neal, A. Mahal, A. Mahal, H. Popper, H. Popper, T. Merigan, T. Merigan, W. Robinson, W. Robinson, P. Gregory, P. Gregory, P. Gregory (1981)Antiviral treatment of chronic hepatitis B virus infection: Improvement in liver disease with interferon and adenine arabinoside
J. Hilfenhaus, E. Weinmann, M. Majer, R. Barth, O. Jaeger (1977)Administration of human interferon to rabies virus-infected monkeys after exposure.
The Journal of infectious diseases, 135 5
J. McCarthy, R. Furner, K. Dyke, R. Stitzel (1970)Effects of malarial infection on host microsomal drug-metabolizing enzymes.
Biochemical pharmacology, 19 4
J. Quesada, J. Gutterman, E. Hersh (1986)Treatment of hairy cell leukemia with alpha interferons
K. Renton, J. Gray, R. Hall (1980)Decreased elimination of theophylline after influenza vaccination.
Canadian Medical Association journal, 123 4
E. Clercq, T. Merigan (1971)Bis-DEAE-fluorenone: mechanism of antiviral protection and stimulation of interferon production in the mouse.
The Journal of infectious diseases, 123 2
Rokea Azhary, K. Renton, G. Mannering (1980)Effect of interferon inducing agents (polyriboinosinic acid . polyribocytidylic acid and tilorone) on the heme turnover of hepatic cytochrome P-450.
Molecular pharmacology, 17 3
F. Besançon, H. Ankel, S. Basu (1976)Specificity and reversibility of interferon ganglioside interaction
M. Yaron, I. Yaron, D. Gurari-Rotman, M. Revel, H. Lindner, U. Zor, (1977)Stimulation of prostaglandin E production in cultured human fibroblasts by poly(I) · poly(C) and human interferon
R. Adamson, S. Fabro (1969)Toxic Properties of a Synthetic Double-stranded RNA: Embryotoxic Effect of Poly I.Poly C
I. Gresser (1982)Can interferon induce disease?
Wooles Wr, Munson Ae (1971)The effect of stimulants and depressants of reticuloendothelial activity on drug metabolism.
Journal of the Reticuloendothelial Society, 9 2
H. Shertzer, J. Hall, J. Seed (1981)Hepatic mixed-function oxidase activity in mice infected with Trypanosoma brucei gambiense or treated with trypanocides.
Molecular and biochemical parasitology, 3 4
P. Fisher, A. Miranda, L. Babiss, S. Pestka, I. Weinstein (1983)Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures.
Proceedings of the National Academy of Sciences of the United States of America, 80 10
L. Deloria, V. Abbott, N. Gooderham, G. Mannering (1985)Induction of xanthine oxidase and depression of cytochrome P-450 by interferon inducers: genetic difference in the responses of mice.
Biochemical and biophysical research communications, 131 1
A. Isaacs, J. Lindenmann, R. Valentine (1957)Virus interference. II. Some properties of interferon
Proceedings of the Royal Society of London. Series B - Biological Sciences, 147
B. Vialettes, D. Baume, C. Charpin, J. Maeyer‐Guignard, P. Vague (1983)Assessment of viral and immune factors in EMC virus-induced diabetes: effects of cyclosporin A and interferon.
Journal of clinical & laboratory immunology, 10 1
T. Merigan, J. Gallagher, R. Pollard, A. Arvin (1981)Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer
Antimicrobial Agents and Chemotherapy, 19
S. Abreu (1983)Pharmacokinetics of rat fibroblast interferon.
The Journal of pharmacology and experimental therapeutics, 226 1
L. Pickering, L. Kronenberg, W. Stewart (1980)Spontaneous production of human interferon.
Proceedings of the National Academy of Sciences of the United States of America, 77 10
R. El-Azhary, G. Mannering (1979)Effects of interferon inducing agents (polyriboinosinic acid. Polyribocytidylic acid, tilorone) on hepatic hemoproteins (cytochrome P-450, catalase, tryptophan 2,3-dioxygenase, mitochondrial cytochromes), heme metabolism and cytochrome P-450-linked monooxygenase systems.
Molecular pharmacology, 15 3
K. Renton (1979)The deleterious effect of Bordetella pertussis vaccine and poly(rI.rC) on the metabolism and disposition of phenytoin.
The Journal of pharmacology and experimental therapeutics, 208 2
M. Thabrew, C. Ioannides (1984)Inhibition of rat hepatic mixed function oxidases by antimalarial drugs: selectivity for cytochromes P-450 and P-448.
Chemico-biological interactions, 51 3
D. Morton, D. Chatfield (1970)The effects of adjuvant-induced arthritis on the liver metabolism of drugs in rats.
Biochemical pharmacology, 19 2
G. Scott, D. Secher, D. Flowers, J. Bate, K. Cantell, D. Tyrrell (1981)Toxicity of interferon.
British Medical Journal (Clinical research ed.), 282
T. Ruzicka, G. Goerz, W. Vizethum, J. Krátká (1980)Effects of intravenous and intracutaneous bacillus Calmette-Guérin application on the drug-metabolizing system of the liver.
Dermatologica, 160 2
N. Dafny, M. Zielinksi, C. Reyes-vazquez (1983)Alteration of morphine withdrawal to naloxone by interferon
F. Fitzpatrick, D. Stringfellow (1980)Virus and interferon effects on cellular prostaglandin biosynthesis.
Journal of immunology, 125 1
A. Paine (1978)Excited states of oxygen in biology: their possible involvement in cytochrome P450 linked oxidations as well as in the induction of the P450 system by many diverse compounds.
Biochemical pharmacology, 27 14
T. Corbett, P. Nettesheim (1973)Effect of PR-8 viral respiratory infection of benz[a]pyrene hydroxylase activity in BALB/c mice.
Journal of the National Cancer Institute, 50 3
A. Isaacs, J. Lindenmann (1957)Virus interference. I. The interferon
Proceedings of the Royal Society of London. Series B - Biological Sciences, 147
B. Bloom (1980)Interferons and the immune system
H. Heremans, A. Billiau, P. Somer (1980)Interferon in experimental viral infections in mice: tissue interferon levels resulting from the virus infection and from exogenous interferon therapy
Infection and Immunity, 30
T. Lampidis, D. Brouty‐boye (1981)Interferon Inhibits Cardiac Cell Function in Vitro
Proceedings of the Society for Experimental Biology and Medicine, 166
C. Harned, D. Nerland, G. Sonnenfeld (1982)Effects of passive transfer and induction of gamma (type II immune) interferon preparations on the metabolism of diphenylhydantoin by murine cytochrome P-450.
Journal of interferon research, 2 1
R. Moore, L. Berry, R. Garry, M. Waite (1978)Effect of Sindbis Virus Infection on Hydrocortisone-induced Hepatic Enzymes in Mice
Proceedings of the Society for Experimental Biology and Medicine, 157
V. Bocci (1984)Evaluation of routes of administration of interferon in cancer: a review and a proposal.
Cancer drug delivery, 1 4
J. Maeyer‐Guignard, A. Cachard, E. Maeyer (1980)Electrophoretically pure mouse interferon has priming but no blocking activity in poly(I.C)-induced cells.
Virology, 102 1
I. Kerr, R. Brown, L. Ball (1974)Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment
Y. Satoh, K. Kasama, A. Kajita, H. Shimizu, N. Ida (1984)Different pharmacokinetics between natural and recombinant human interferon beta in rabbits.
Journal of interferon research, 4 3
J. Crooks, K. O'malley, I. Stevenson (1976)Pharmacokinetics in the Elderly
Clinical Pharmacokinetics, 1
R. Friedman, I. Pastan (1969)Interferon and cyclic-3'5'-adenosine monophosphate: potentiation of antiviral activity.
Biochemical and biophysical research communications, 36 5
T. Timonen, J. Ortaldo, R. Herberman (1981)Characteristics of human large granular lymphocytes and relationship to natural killer and K cells
The Journal of Experimental Medicine, 153
P. Came, W. Carter (1984)Interferon: its application and future as an antineoplastic agent
Drugs and the pharmaceutical sciences, 24
J. Gordon, M. Minks (1981)The interferon renaissance: molecular aspects of induction and action.
Microbiological reviews, 45 2
T. Timonen, E. Saksela, I. Virtanen, K. Cantell (1980)Natural killer cells are responsible for the interferon production induced in human lymphocytes by tumor cell contact
European Journal of Immunology, 10
Michael Rosenblum, Barbara Unger, J. Gutterman, Evan Hersh, Gary David, James Frincke (1985)Modification of human leukocyte interferon pharmacology with a monoclonal antibody.
Cancer research, 45 6
Gilbert J. Mannering and Laurel B. Deloria Department of Pharmacology , University of Minnesota School of Medicine, MinneapoÂ lis, Minnesota 55455 INTRODUCTION2 Early virologists observed that a patient or an experimental animal, once recovered from a virus infection usually resisted reinfection from the same or similar virus. Vaccination was one of the early applications of this phenomÂ enon, which was termed viral interference. As immunology evolved, inÂ vestigators recognized that the infected body produces specific antiviral antiÂ bodies which appear in the circulation and on mucous surfaces attacked by viruses (humoral immunity), or that sensitized cells (principally lymphocytes) appear which can attack both virus particles and cells infected by viruses (cell-mediated immunity). The requirement of specific antibodies for specific viruses limited the general clinical usefulness of humoral and cell-mediated immunity. As experience with cell cultures evolved, it became apparent with several experimental models that infection of cells with one virus protected against reinfection with an antigenically unrelated virus. The groundwork for the discovery of interferon was laid by Henle & Henle (6) in 1943 when they demonstrated interference between inactive and active influenza viruses in the developing chick embryo, but the mechanism of this type of interference was
Annual Review of Pharmacology and Toxicology – Annual Reviews
Published: Apr 1, 1986
Access the full text.
Sign up today, get DeepDyve free for 14 days.